Literature DB >> 25800888

Genetic Association Between KIBRA Polymorphism and Alzheimer's Disease with in a Japanese Population.

Eri Kawai1, Nobuto Shibata, Tomoyuki Nagata, Shunichiro Shinagawa, Kenji Tagai, Kenji Tgai, Tohru Ohnuma, Hiromi Shimazaki, Aiko Toda, Koji Kasanuki, Toshiki Takayama, Ayako Suzuki, Kazuhiko Nakayama, Hisashi Yamada, Heii Arai.   

Abstract

KIBRA plays an important role in synaptic plasticity in human hippocampus related to cognitive function. Functional studies suggest that KIBRA is a potential candidate gene for memory and Alzheimer's disease (AD) risk. A single nucleotide polymorphism, Rs17070145 C allele affects the onset of AD in an age-dependent manner comparing with T/T genotypes and is also associated with risk of substance abuse and relapse. The aim of this case-control study was to investigate whether the rs17070145 polymorphism affected the onset of AD in an age-dependent manner in a Japanese population. We analysed KIBRA and APOE genotypes in 237 young AD cases, 154 age-matched control cases and 160 old AD cases. The analyses were performed by stratifying alcohol consumption and the APOE status. We used single photon emission computed tomography (SPECT) to analyse patients with AD with the rs17070145 polymorphism. The genotypic and allelic frequencies of the young AD group differed significantly from those of control and old AD groups. There was a significant association among high alcohol consumption (HAC-AD group) and the genotypic and allelic frequencies of the rs17070145 polymorphism. Logistic regression analyses demonstrate synergism between the APOE genotype and the rs17070145 C allele to increase the risk of AD in the young group; this was confirmed in the HAC-AD group. The SPECT study revealed hyperperfusion in the C allele carrier group was detected in the right inferior frontal gyrus compared with the T/T group. KIBRA rs17070145 affects specific phenotypes of patients with AD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25800888     DOI: 10.1007/s12017-015-8348-8

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  31 in total

Review 1.  Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.

Authors:  Vincenza Frisardi; Vincenzo Solfrizzi; Davide Seripa; Cristiano Capurso; Andrea Santamato; Daniele Sancarlo; Gianluigi Vendemiale; Alberto Pilotto; Francesco Panza
Journal:  Ageing Res Rev       Date:  2010-05-02       Impact factor: 10.895

2.  Association study of KIBRA gene with memory performance in a Japanese population.

Authors:  Yuka Yasuda; Ryota Hashimoto; Kazutaka Ohi; Motoyuki Fukumoto; Hironori Takamura; Naomi Iike; Tetsuhiko Yoshida; Noriyuki Hayashi; Hidetoshi Takahashi; Hidenaga Yamamori; Takashi Morihara; Shinji Tagami; Masayasu Okochi; Toshihisa Tanaka; Takashi Kudo; Kouzin Kamino; Ryohei Ishii; Masao Iwase; Hiroaki Kazui; Masatoshi Takeda
Journal:  World J Biol Psychiatry       Date:  2010-10       Impact factor: 4.132

3.  Association of common KIBRA variants with episodic memory and AD risk.

Authors:  Jeremy D Burgess; Otto Pedraza; Neill R Graff-Radford; Meron Hirpa; Fanggeng Zou; Richard Miles; Thuy Nguyen; Ma Li; John A Lucas; Robert J Ivnik; Julia Crook; V Shane Pankratz; Dennis W Dickson; Ronald C Petersen; Steven G Younkin; Nilüfer Ertekin-Taner
Journal:  Neurobiol Aging       Date:  2010-12-24       Impact factor: 4.673

4.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

5.  Association of KIBRA and memory.

Authors:  Timothy C Bates; Jackie F Price; Sarah E Harris; Riccardo E Marioni; F Gerry R Fowkes; Marlene C Stewart; Gordon D Murray; Lawrence J Whalley; John M Starr; Ian J Deary
Journal:  Neurosci Lett       Date:  2009-05-03       Impact factor: 3.046

6.  KIBRA genetic polymorphism influences episodic memory in Alzheimer's disease, but does not show association with disease in a Japanese cohort.

Authors:  Noriyuki Hayashi; Hiroaki Kazui; Kouzin Kamino; Hiromasa Tokunaga; Masahiko Takaya; Mikiko Yokokoji; Ryo Kimura; Yumiko Kito; Tamiki Wada; Keiko Nomura; Hiromichi Sugiyama; Daisuke Yamamoto; Tetsuhiko Yoshida; Antonio Currais; Salvador Soriano; Toshimitsu Hamasaki; Mitsuko Yamamoto; Yuka Yasuda; Ryota Hashimoto; Hitoshi Tanimukai; Shinji Tagami; Masayasu Okochi; Toshihisa Tanaka; Takashi Kudo; Takashi Morihara; Masatoshi Takeda
Journal:  Dement Geriatr Cogn Disord       Date:  2010-09-25       Impact factor: 2.959

7.  Cognitive flexibility is associated with KIBRA variant and modulated by recent tobacco use.

Authors:  Huiping Zhang; Henry R Kranzler; James Poling; Jeffrey R Gruen; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2009-07-15       Impact factor: 7.853

8.  KIBRA: A New Gateway to Learning and Memory?

Authors:  Armin Schneider; Matthew J Huentelman; Joachim Kremerskothen; Kerstin Duning; Robert Spoelgen; Karoly Nikolich
Journal:  Front Aging Neurosci       Date:  2010-02-12       Impact factor: 5.750

9.  Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease.

Authors:  Christiane Möller; Hugo Vrenken; Lize Jiskoot; Adriaan Versteeg; Frederik Barkhof; Philip Scheltens; Wiesje M van der Flier
Journal:  Neurobiol Aging       Date:  2013-04-03       Impact factor: 4.673

10.  KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment.

Authors:  O P Almeida; S G Schwab; N T Lautenschlager; B Morar; K R Greenop; L Flicker; D Wildenauer
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

View more
  2 in total

1.  Distinctive phosphoinositide- and Ca2+-binding properties of normal and cognitive performance-linked variant forms of KIBRA C2 domain.

Authors:  Mareike G Posner; Abhishek Upadhyay; Rieko Ishima; Antreas C Kalli; Gemma Harris; Joachim Kremerskothen; Mark S P Sansom; Susan J Crennell; Stefan Bagby
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

2.  Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment.

Authors:  Nobuyuki Kobayashi; Shunichiro Shinagawa; Tomoyuki Nagata; Kazuya Shimada; Nobuto Shibata; Tohru Ohnuma; Koji Kasanuki; Heii Arai; Hisashi Yamada; Kazuhiko Nakayama; Kazuhiro Kondo
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.